Zhifei Attends 2023 World Lung Health Conference and Visits World Health Organization

Release time:2023-12-27  |  Click rate:

From November 15th to 18th, the Union World Conference on Lung Health, the most prestigious academic conference in the field of global tuberculosis prevention and control, was held in Paris, France. Zhifei was invited to attend the meeting. Pu Jiang, the company's vice president, delivered a themed report on "Research on the Clinical Safety and Effectiveness of Vaccae" and introduced the use of Mycobacterium Vaccae (trade name: "Vaccae") to prevent tuberculosis in people with latent tuberculosis infection, and shared domestic experience in tuberculosis prevention and control. As the world's first successfully developed immune preparation to prevent tuberculosis in people with latent tuberculosis infection since the introduction of the BCG vaccine over a century ago, "Vaccae" has attracted widespread attention from participants at the conference.


On November 20th and 21st, the team visited well-known international organizations such as World Health Organization (WHO), the Global Fund, and the STOP TB Partnership in Geneva, Switzerland, to discuss the company's full range of products. They conducted in-depth exchanges on the research and development progress of product development and international cooperation to promote the company's internationalization progress.


At present, Zhifei has carried out market registration of tuberculosis products in Indonesia, Pakistan, Uzbekistan and other countries, and will launch a series of international clinical studies.

Zhifei will continue to fulfill its mission of "Safeguarding human health, by preventing the unseen and treating the ailing", strengthen exchanges and cooperation with international organizations, continue to expand international market, and make positive contributions to the prevention and control of human diseases.

About The Union World Conference on Lung Health:
The World Lung Health Conference is hosted by the International Federation against Tuberculosis and Lung Disease. It is the largest academic exchange event in the field of tuberculosis in the world and has been in existence for more than 100 years. The conference brings together clinicians, public health workers and researchers from all over the world to alleviate the suffering caused by lung diseases, especially tuberculosis.
About the World Health Organization (WHO):
The World Health Organization is a specialized agency under the United Nations, headquartered in Geneva, Switzerland. It is the largest intergovernmental health organization in the world. The purpose of the World Health Organization is to achieve the highest possible level of health for people around the world.
About The Global Fund:
The full name of the Global Fund is the "Global Fund to Fight AIDS, Tuberculosis and Malaria". It is dedicated to fighting AIDS, tuberculosis and malaria. It is an international financial institution jointly founded by the government and the private sector, and is headquartered in Geneva, Switzerland. Since its establishment in 2002, its business has now covered more than 150 countries and regions, and it has so far committed US$2.17 billion to support large-scale prevention, treatment and care projects in 150 countries to combat these three diseases.
About the STOP TB Partnership:
The Global Partnership for Tuberculosis Control was established in 2000 to eliminate tuberculosis as a global public health problem. It was founded by Lee Jong-Wook, former Director-General of the World Health Organization. It is internationally recognized as one of the most successful and dynamic global public health organization.